The results of recent trials that tested much-anticipated Alzheimer's disease drugs dashed the hopes of patients with the debilitating condition. The most recent disappointment came from the large trial for solanezumab, by Eli Lilly, announced last month.
원문출처 : http://www.cnn.com/2016/12/09/health/alzheimers-drug-by-2025/index.html
원문출처 : http://www.cnn.com/2016/12/09/health/alzheimers-drug-by-2025/index.html